Scientific Opinion on the substantiation of a health claim related to vitamin D and contribution to the normal function of the immune system pursuant to Article 14 of Regulation (EC) No 1924/2006
Carlo Agostoni, Roberto Berni Canani, Susan Fairweather-Tait, Marina Heinonen, Hannu Korhonen, La Sébastien, Rosangela Vieille, Ambroise Marchelli, Androniki Martin, Monika Naska, Grażyna Neuhäuser-Berthold, Yolanda Nowicka, Alfonso Sanz, Anders Siani, Martin Sjödin, Sean Stern, J J ) Strain, Inge Tetens, Daniel Tomé, Dominique Turck, Jean-Louis Bresson, Ambroise Martin, Hildegard Przyrembel, Yolanda Sanz
EFSA Journal, doi:10.2903/j.efsa.2015.4096
Following an application from VAB-nutrition, submitted for authorisation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of France, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to vitamin D and contribution to the normal function of the immune system. The Panel considers that vitamin D is sufficiently characterised. Contribution to the normal function of the immune system is a beneficial physiological effect for children. The Panel had previously assessed a claim on vitamin D and contribution to the normal function of the immune system with a favourable outcome. The target population was the general population. The Panel considered that vitamin D plays a regulatory role in the functioning of the immune system. The Panel considers that the role of vitamin D in the functioning of the immune system applies to all ages, including children. The Panel concludes that a cause and effect relationship has been established between the dietary intake of vitamin D and contribution to the normal function of the immune system. The following wording reflects the scientific evidence: "Vitamin D contributes to the normal function of the immune system". The target population is children from 3 to 18 years of age.
{ 'type': 'article-journal',
'language': 'eng',
'journalAbbreviation': 'EFS2',
'author': [{'literal': 'EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)'}],
'issued': {'date-parts': [[2015, 5]]},
'abstract': 'Abstract Following an application from VAB‐nutrition, submitted for authorisation of a health '
'claim pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of '
'France, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to '
'deliver an opinion on the scientific substantiation of a health claim related to vitamin D '
'and contribution to the normal function of the immune system. The Panel considers that '
'vitamin D is sufficiently characterised. Contribution to the normal function of the immune '
'system is a beneficial physiological effect for children. The Panel had previously assessed a '
'claim on vitamin D and contribution to the normal function of the immune system with a '
'favourable outcome. The target population was the general population. The Panel considered '
'that vitamin D plays a regulatory role in the functioning of the immune system. The Panel '
'considers that the role of vitamin D in the functioning of the immune system applies to all '
'ages, including children. The Panel concludes that a cause and effect relationship has been '
'established between the dietary intake of vitamin D and contribution to the normal function '
'of the immune system. The following wording reflects the scientific evidence: “Vitamin D '
'contributes to the normal function of the immune system”. The target population is children '
'from 3 to 18 years of age.',
'container-title': 'EFSA Journal',
'container-title-short': 'EFS2',
'DOI': '10.2903/j.efsa.2015.4096',
'ISSN': '18314732, 18314732',
'issue': '5',
'keyword': 'Opinion; Opinions; vitamin D; immune system; children; health claims',
'medium': 'JB',
'publisher-place': 'IT',
'title': 'Scientific Opinion on the substantiation of a health claim related to vitamin D and contribution '
'to the normal function of the immune system pursuant to Article 14 of Regulation (EC) No '
'1924/2006',
'URL': 'https://data.europa.eu/doi/10.2903/j.efsa.2015.4096',
'volume': '13'}
